[recIndex] (https://github.com/johnnybender/adastandards2016/blob/master/index/recIndex.md)

### **Individuals with type 1 diabetes who have been successfully using continuous subcutaneous insulin infusion should have continued access to this therapy after they turn 65 years of age.**
* Unique ID: rec129
* Evidence Letter: E
* Category Name: PHARMACOLOGIC THERAPY FOR TYPE 1 DIABETES
* Page: S64
* Feasible: Yes
* Type: Rec
* Comments: 

#### Race Codes:

Description | Codes
----------- | -----


#### Ethnicity Codes:

Description | Codes
----------- | -----
|

#### ICD-9 Codes:

Description | Codes
----------- | -----
|

#### ICD-10 Codes:

Description | Codes
----------- | -----
|

#### ICD-10 PCS Codes:

Description | Codes
----------- | -----
|

#### SNOMED Codes:

Description | Codes
----------- | -----
|

#### CPT Codes:

Description | Codes
----------- | -----
|

#### HCPCS Codes:

Description | Codes
----------- | -----
|

#### LOINC Codes:

Description | Codes
----------- | -----
|

#### CVX Codes:

Description | Codes
----------- | -----
|

#### AHFS Medication Class:

Description | Codes
----------- | -----
|

#### RxNorm:

Description | Codes
----------- | -----
|

#### Miscellaneous Codes:

Description | Dictionary | Codes
----------- | ---------- | -----
|

#### Modules:

Module |
------ |
|

#### Implementation:
